TY  - GEN
AU  - Pressiat,Claire
AU  - Mea-Assande,Veronique
AU  - Yonaba,Caroline
AU  - Treluyer,Jean-Marc
AU  - Dahourou,Désiré-Lucien
AU  - Amorissani-Folquet,Madeleine
AU  - Blanche,Stéphane
AU  - Eboua,François
AU  - Ye,Diarra
AU  - Lui,Gabrielle
AU  - Malateste,Karen
AU  - Zheng,Yi
AU  - Leroy,Valeriane
AU  - Hirt,Déborah
TI  - Suboptimal cotrimoxazole prophylactic concentrations in HIV-infected children according to the WHO guidelines
SN  - 1365-2125
PY  - 2018///0131
KW  - AIDS-Related Opportunistic Infections
KW  - immunology
KW  - Administration, Oral
KW  - Anti-Bacterial Agents
KW  - administration & dosage
KW  - Burkina Faso
KW  - Child, Preschool
KW  - Coinfection
KW  - Computer Simulation
KW  - Cote d'Ivoire
KW  - Female
KW  - HIV Infections
KW  - drug therapy
KW  - HIV Protease Inhibitors
KW  - therapeutic use
KW  - Humans
KW  - Infant
KW  - Lopinavir
KW  - Male
KW  - Metabolic Clearance Rate
KW  - Models, Biological
KW  - Nonlinear Dynamics
KW  - Pneumonia, Pneumocystis
KW  - Practice Guidelines as Topic
KW  - Trimethoprim, Sulfamethoxazole Drug Combination
KW  - World Health Organization
N1  - Publication Type: Clinical Trial, Phase III; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1111/bcp.13397
ER  -